Md. Maruf Billah
Pharmaceutical Marketer
Dhaka
Summary
Bringing over 11 years of experience as a marketer in the pharmaceutical industry, I am currently employed at Square Pharmaceuticals PLC for more than 8 years. I feel honored to have the opportunity to work with Square's Cardiovascular Portfolio since joining
Overview
11
11
years of professional experience
11
11
years of post-secondary education
Work History
Senior Product Executive (M-13), PMD
Square Pharmaceuticals PLC.
Dhaka
01.2021 - Current
- Looking after the most value-earning therapeutic class of the Square Cardiovascular Portfolio, 'Angiotensin Receptor Blockers & its combination (Angilock, Angilock Plus, Telmilok, Olmecar)
- Implementing a 360-degree promotion for Telmilok has successfully elevated its position from 6th to 4th in IMS (IQVIA)
- Launched Adsalt 300 (Sodium Chloride 300 mg Tablet), the first in the Electrolyte Replenisher Therapeutic class of Square
Product Executive (M-14), PMD
Square Pharmaceutical PLC.
Dhaka
01.2018 - 12.2020
- Prepared Monthly Target of total Cardiovascular portfolio through different strategical analysis
- Launched Hyponor injection: 1st product of Square Anti-hypotensive therapeutic class.
- Successfully Launched Bisocam (Bisoprolol & Amlodipine Combination) & Nebita Plus (Nebivlolol & Hydrochlorothiazide combination)
- Added 6.5 Cr. Value in a single year (2020) with Beta blocker & Combinations (Major Brands: Bisocor & Nebita)
Product Executive (M-15), PMD
Square Pharmaceuticals PLC.
Dhaka
07.2015 - 12.2017
- Pre & Post Branding Concept implemented on my major brand Nebita (Nebivolol) which create strong baseline for next success. When I started to look after this brand (in 2015), its value was 3.16 Cr (IQVIA). But when I left this brand (in 2022), the value was 21.33 Cr. (IQVIA).
- Launched Ticagrelor (Ticalog). Developed Patient helping Card for the patient to make it easily available anywhere (As this is a niche product)
- Successfully arranged family engagement program with the Doctors & their family to build a good relationship with them.
Product Executive, PMD
General Pharmaceutical Ltd.
Dhaka
10.2012 - 07.2015
- Cephalosporin Portfolio specially completed all launching work of Secoclav (Cefuroxime & Clavulanic Acid Combination) and successfully handled Brand Secomax.
- Made the Helicon Kit (indicated in Peptic Ulcer caused by H. Pylori) again the brand leader among triple therapy market
- Launched Genevir (Entecavir)
Education
MBA - Marketing
Bangladesh University of Professionals
Dhaka 01.2014 - 03.2016
B. Pharm -
Khulna University
Khulna, Bangladesh 01.2008 - 11.2012
HSC - Science
New Govt. Degree College
Rajshahi, Bangladesh 01.2004 - 12.2005
SSC - Science
Masjid Mission Academy
Rajshahi, Bangladesh 01.2002 - 12.2003
Skills
Marketing Strategy
Brand Management
Pharmaceutical Sales
Business Planning
Marketing Management
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Timeline
Senior Product Executive (M-13), PMD
Square Pharmaceuticals PLC.
01.2021 - Current
Product Executive (M-14), PMD
Square Pharmaceutical PLC.
01.2018 - 12.2020
Product Executive (M-15), PMD
Square Pharmaceuticals PLC.
07.2015 - 12.2017
MBA - Marketing
Bangladesh University of Professionals
01.2014 - 03.2016
Product Executive, PMD
General Pharmaceutical Ltd.
10.2012 - 07.2015
B. Pharm -
Khulna University
01.2008 - 11.2012
HSC - Science
New Govt. Degree College
01.2004 - 12.2005
SSC - Science
Masjid Mission Academy
01.2002 - 12.2003